The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering

Biomaterials

Volumn 32, Issue 30, 2011, Pages 7503-7513

  Zhou, Hongzhi ^a   Xu, Hockin H K ^a,b,c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c University of Marylandw Baltimore County   (United States)

Author keywords

Alginate fibrin microbeads; Cell release; Fast degradable hydrogel; Human umbilical cord stem cells; Osteodifferentiation and mineralization; Tissue engineering

Indexed keywords

BONE MARKERS; BONE MINERALS; BONE TISSUE ENGINEERING; COLLAGEN I; FAST-DEGRADABLE HYDROGEL; HUMAN UMBILICAL CORD; LIVE CELL; MESENCHYMAL STEM CELL; MICROBEADS; OSTEODIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; RELEASED CELLS; TISSUE REGENERATION;

ALGINATE; BONE; CELL CULTURE; DEGRADATION; ENCAPSULATION; GENE EXPRESSION; HYDROGELS; SILICATE MINERALS; STEM CELLS; TISSUE;

SCAFFOLDS (BIOLOGY);

ALGINIC ACID; ALIZARIN; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; FIBRIN; NANOBEAD; OSTEOCALCIN; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE MINERALIZATION; BONE TISSUE; CELL DENSITY; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NANOFABRICATION; OSTEOBLAST; OXIDATION; PRIORITY JOURNAL; SYNTHESIS; TISSUE ENGINEERING;

ALGINATES; BONE AND BONES; CELL DIFFERENTIATION; CELLS, CULTURED; FIBRIN; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGEL; MESENCHYMAL STEM CELLS; MICROSPHERES; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; UMBILICAL CORD;

EID: 80051550620     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.045     Document Type: Article

References (53)

1. Lavik E., Langer R. Tissue engineering: current state and perspectives. Appl Microbiol Biotech 2004, 65:1-8.
2. Hill E., Boontheekul T., Mooney D.J. Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng 2006, 12:1295-1304.
3. Mao J.J., Giannobile W.V., Helms J.A., Hollister S.J., Krebsbach P.H., Longaker M.T., et al. Craniofacial tissue engineering by stem cells. J Dent Res 2006, 85:966-979.
4. Salinas C.N., Anseth K.S. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J Tissue Eng Reg Med 2008, 2:296-304.
5. Atala A. Engineering organs. Curr Opin Biotechnol 2009, 20:575-592.
6. Kretlow J.D., Young S., Klouda L., Wong M., Mikos A.G. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 2009, 21:3368-3393.
7. Aoki T., Ohnishi H., Oda Y., Tadokoro M., Sasao M., Kato H., et al. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Eng A 2010, 16:2197-2206.
8. Gomes M.E., Mikos A.G., Reis R.L. Injectable polymeric scaffolds for bone tissue engineering. Biodegradable systems in tissue engineering and regenerative medicine 2004, 29-38. CRC Press, Boca Raton, FL. R.L. Reis, J. San Roman (Eds.).
9. Mikos A.G., Herring S.W., Ochareon P., Elisseeff J., Lu H.H., Kandel R., et al. Engineering complex tissues. Tissue Eng 2006, 12:3307-3339.
10. Johnson P.C., Mikos A.G., Fisher J.P., Jansen J.A. Strategic directions in tissue engineering. Tissue Eng 2007, 13:2827-2837.
11. Mao J.J., Vunjak-Novakovic G., Mikos A.G., Atala A. Regenerative medicine: Translational approaches and tissue engineering 2007, Artech House, Boston, MA.
12. Praemer A., Furner S., Rice D.P. Musculoskeletal conditions in the United States 1999, Amer Acad Orthop Surg, Rosemont, IL.
13. Jansen J.A., Vehof J.W.M., Ruhe P.Q., Kroeze-Deutman H., Kuboki Y., Takita H., et al. Growth factor-loaded scaffolds for bone engineering. J Control Release 2005, 101:127-136.
14. Benoit D.S.W., Nuttelman C.R., Collins S.D., Anseth K.S. Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 2006, 27:6102-6110.
15. Reilly G.C., Radin S., Chen A.T., Ducheyne P. Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. Biomaterials 2007, 28:4091-4097.
16. Sarugaser R., Lickorish D., Baksh D., Hosseini M.M., Davies J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005, 23:220-229.
17. Varghese S., Hwang N.S., Ferran A., Hillel A., Theprungsirikul P., Canver A.C., et al. Engineering musculoskeletal tissues with human embryonic germ cell derivatives. Stem Cells 2010, 28:765-774.
18. Drury J.L., Mooney D.J. Review. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003, 24:4337-4351.
19. Drury J.L., Dennis R.G., Mooney D.J. The tensile properties of alginate hydrogels. Biomaterials 2004, 25:3187-3199.
20. Bouhadir K.H., Lee K.Y., Alsberg E., Damm K.L., Anderson K.W., Mooney D.J. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 2001, 17:945-950.
21. Zhao L., Weir M.D., Xu H.H.K. An injectable calcium phosphate - alginate hydrogel - umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 2010, 31:6502-6510.
22. Xu H.H.K., Zhao L., Weir M.D. Stem cell-calcium phosphate constructs for bone engineering. J Dent Res 2010, 89:1482-1488.
23. Atrah H.I. Fibrin glue. Br Med J 1994, 308:933-934.
24. Ahmed T.A., Dare E.V., Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng B 2008, 14:199-215.
25. Gorodetsky R., Levdansky L., Gaberman E., Gurevitch O., Lubzens E., McBride W.H. Fibrin microbeads (FMB) loaded with mesenchymal cells support their long term survival while sealed at room temperature. Tissue Eng C 2011, [Epub ahead of print].
26. Perka C., Arnold U., Spitzer R.S., Lindenhayn K. The use of fibrin beads for tissue engineering and subsequential transplantation. Tissue Eng 2001, 7:359-361.
27. Spitzer R.S., Perka C., Lindenhayn K., Zippel H. Matrix engineering for osteogenic differentiation of rabbit periosteal cells using alpha-tricalcium phosphate particles in a three-dimensional fibrin culture. J Biomed Mater Res 2002, 59:690-696.
28. Arnold U., Schweitzer S., Lindenhayn K., Perka C. Optimization of bone engineering by means of growth factors in a three-dimensional matrix. J Biomed Mater Res A 2003, 67:260-269.
29. Wang H.S., Hung S.C., Peng S.T. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004, 22:1330-1337.
30. Bailey M.M., Wang L., Bode C.J., Mitchell K.E., Detamore M.S. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 2007, 13:2003-2010.
31. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
32. Wang L., Singh M., Bonewald L.F., Detamore M.S. Signaling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Reg Med 2009, 3:398-404.
33. Zhao L., Weir M.D., Xu H.H.K. Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 2010, 31:3848-3857.
34. Simon C.G., Guthrie W.F., Wang F.W. Cell seeding into calcium phosphate cement. J Biomed Mater Res A 2004, 68:628-639.
35. Weir M.D., Xu H.H.K., Simon C.G. Strong calcium phosphate cement-chitosan-mesh construct containing cell-encapsulating hydrogel beads for bone tissue engineering. J Biomed Mater Res A 2006, 77:487-496.
36. Xu H.H.K., Zhao L., Detamore M.S., Takagi S., Chow L.C. Umbilical cord stem cell seeding on fast-resorbable calcium phosphate bone cement. Tissue Eng A 2010, 16:2743-2753.
37. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt Method. Methods 2001, 25:402-408.
38. Kim K., Dean D., Mikos A.G., Fisher J.P. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules 2009, 10:1810-1817.
39. Wang Y.H., Liu Y., Maye P., Rowe D.W. Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotech Prog 2006, 22:1697-1701.
40. Jäger M., Degistirici O., Knipper A., Fischer J., Sager M., Krauspe R. Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation. J Bone Miner Res 2007, 22:1224-1233.
41. Wang L., Dormer N.H., Bonewald L.F., Detamore M.S. Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds. Tissue Eng A 2010, 16:1937-1948.
42. Can A., Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007, 25:2886-2895.
43. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.
44. Diao Y., Ma Q., Cui F., Zhong Y. Human umbilical cord mesenchymal stem cells: osteogenesis in vivo as seed cells for bone tissue engineering. J Biomed Mater Res A 2009, 91:123-131.
45. Evangelista M.B., Hsiong S.X., Fernandes R., Sampaio P., Kong H.J., Barrias C.C., et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 2007, 28:3644-3655.
46. Nuttelman C.R., Tripodi M.C., Anseth K.S. In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels. J Biomed Mater Res A 2004, 68:773-782.
47. Markusen J.F., Mason C., Hull D.A., Town M.A., Tabor A.B., Clements M., et al. Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng 2006, 12:821-830.
48. Kong H.J., Smith M.K., Mooney D.J. Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials 2003, 24:4023-4029.
49. Boontheekul T., Kong H.J., Mooney D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 2005, 26:2455-2465.
50. Datta N., Pha Q.P., Sharma U., Sikavitsas V.I., Jansen J.A., Mikos A.G. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci USA 2006, 103:2488-2493.
51. Radin S., Reilly G., Bhargave G., Leboy P.S., Ducheyne P. Osteogenic effects of bioactive glass on bone marrow stromal cells. J Biomed Mater Res A 2005, 73:21-29.
52. Leach J.K., Kaigler D., Wang Z., Krebsbach P.H., Mooney D.J. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 2006, 27:3249-3255.
53. Sundelacruz S., Kaplan D.L. Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Semin Cell Dev Bio 2009, 20:646-655.